Ambulatory blood pressure parameters after canrenone addition to existing treatment regimens with maximum tolerated dose of angiotensin-converting enzyme inhibitors/angiotensin II type 1 receptor blockers plus hydrochlorothiazide in uncontrolled hypertensive patients

Ambulatory blood pressure parameters after canrenone addition to existing treatment regimens with maximum tolerated dose of angiotensin-converting enzyme inhibitors/angiotensin II type 1 receptor blockers plus hydrochlorothiazide in uncontrolled hypertensive patients

Luigina Guasti,1,* Giovanni Gaudio,2,* Alessandro Lupi,3 Marinella D’Avino,4 Carla Sala,5,6 Amedeo Mugellini,7 Vito Vulpis,8 Salvatore Felis,9 Riccardo Sarzani,10,11 Massimo Vanasia,12 Pamela Maffioli,7 Giuseppe Derosa7 1Research Center on Dyslipidemia, Internal Medicine 1, University of...

Full description

Bibliographic Details
Main Authors: Guasti L, Gaudio G, Lupi A, D'Avino M, Sala C, Mugellini A, Vulpis V, Felis S, Sarzani R, Vanasia M, Maffioli P, Derosa G
Format: Article
Language:English
Published: Dove Medical Press 2017-08-01
Series:Drug Design, Development and Therapy
Subjects:
Ambulatory blood pressure
Canrenone
RAAS
ACE inhibitors
AT1R antagonist
Online Access:https://www.dovepress.com/ambulatory-blood-pressure-parameters-after-canrenone-addition-to-exist-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/ambulatory-blood-pressure-parameters-after-canrenone-addition-to-exist-peer-reviewed-article-DDDT

Similar Items